Table 3 Soldier cases compared by presence versus absence of post-acute sequelae of SARS-CoV-2 infection (CV PASC)
CV PASC (N = 7) | No PASC (N = 12) | P value | |
|---|---|---|---|
LVEF, median (IQR), % | 57.8 (57.1, 63.1) | 57.9 (54.7, 61.5) | 0.45 |
LVEDV, mL | 168.1 (164.3, 207.7) | 184.6 (168.1, 206.3) | 0.61 |
LVEDVI, mL/m2 | 84.3 (82.5, 96.0) | 84.3 (81.9, 95.2) | 0.61 |
LVESV, mL | 69.0 (64.3, 81.1) | 74.6 (65.5, 92.1) | 0.35 |
LVESVI, mL/m2 | 34.8 (32.2, 38.3) | 36.4 (32.4, 40.5) | 0.53 |
LV mass, g | 136.4 (127.3, 158.2) | 130.5 (126.2, 140.5) | 0.47 |
LV mass index, g/m2 | 64.8 (62.6, 74.8) | 62.5 (58.7, 66.7) | 0.16 |
RVEF, % | 50.6 (48.3, 52.0) | 50.5 (46.9, 53.2) | 0.87 |
RVEDV mL | 221.0 (192.2, 276.3) | 208.6 (188.3, 226.0) | 0.40 |
RVEDVI, mL/m2 | 107.9 (94.9, 129.3) | 99.6 (88.0, 105.8) | 0.24 |
RVESV, mL | 110.3 (95.1, 135.7) | 105.3 (90.3, 114.4) | 0.55 |
RVESVI, mL/m2 | 55.3 (45.6, 63.5) | 48.4 (47.5, 53.5) | 0.35 |
T1, median (IQR), ms | |||
Mid septum | 986.4 (958.5, 1007.7) | 985.6 (964.0, 994.1) | 0.74 |
Mid lateral | 970.2 (962.2, 983.7) | 973.1 (944.6, 1001.0) | 0.80 |
Mid global | 972.1 (956.0, 1003.6) | 978.5 (953.9, 996.3) | 0.99 |
T2 median (IQR), ms | |||
Mid septum | 45.7 (45.0, 47.4) | 44.7 (43.8, 45.7)b | 0.10 |
Mid lateral | 45.5 (44.6, 45.6) | 45.6 (43.8, 46.1)b | 0.62 |
Mid global | 45.7 (44.8, 47.5) | 45.3 (44.1, 46.1)b | 0.10 |
ECV (global), % | |||
Mid septum | 25.4 (24.1, 26.1)a | 23.4 (22.3, 25.3)b | 0.12 |
Mid lateral | 23.0 (22.5, 24.2)a | 22.1 (20.5, 22.5)b | 0.06 |
Mid global | 23.9 (22.0, 25.7)a | 23.0 (21.3, 23.4)c | 0.36 |
LGE | |||
Any, N (%) | 3 (42.9%) | 1 (9.1%)b | 0.25 |
Inferior RV septal insertion | 1 (14.3%) | 1 (9.1%)b | 0.99 |
Subepicardial inferolateral | 2 (28.6%) | 0 (0%)b | 0.14 |
Diagnosis | |||
Myocarditis | 2 (28.6%) | 0 (0%)b | 0.14 |